Journals / Marmara Medical Journal / 2010 / Cilt: 23 - Sayı: 3

Marmara Üniversitesi Hastanesine varis dışı üst gastrointestinal kanama ile başvuran hastaların değerlendirilmesi

Analysis of the patients admitted to Marmara University Hospital with non-variceal upper gastrointestinal bleeding

Pages
339–346
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Since the etiology of bleeding was amenable to treatment, the rate of endoscopic and surgical treatment and mortality were low in our patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Non-variceal upper gastrointestinal bleeding (NVUGIB) remains an important cause of morbidity and mortality despite the availability of advanced endoscopic techniques for haemostasis.
📊
Key Findings & Data:Method: Two hundred and fifty patients admitted between 1996 and 2001 with acute NVUGIB have been evaluated retrospectively.
💡
Conclusion & Impact:Since the etiology of bleeding was amenable to treatment, the rate of endoscopic and surgical treatment and mortality were low in our patients.
🔬Design:Research Article
📍Scope:2001 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Non-variceal upper gastrointestinal bleeding (NVUGIB) remains an important cause of morbidity and mortality despite the availability of advanced endoscopic techniques for haemostasis. We have described clinical and endoscopic features of the patients with NVUGIB in a teaching hospital. Method: Two hundred and fifty patients admitted between 1996 and 2001 with acute NVUGIB have been evaluated retrospectively. Results: Mean age was 59 and 34.4% were women. Ingestion of aspirin/non-steroidal anti-inflammatory drugs, steroid or warfarin during the previous week was reported for 59.6%, 2.8%, 9.6% of the patients, respectively. Previous upper gastrointestinal bleeding was reported for 31.8% of the patients. The leading cause of bleeding was peptic ulcer (49.2%), followed by erosions (19.2%) and stomach tumors (10.8%). Lesions were located in the stomach (40%), duodenum (33.6%), at the gastrojejunostomy line (4.4%) and esophagus (4.4%). H. pyloric region was positive in 79.2% of the 48 patients investigated. Endoscopic treatment was applied to 33 patients. Seven cases (2.8%) including 3 which had failed endoscopic therapy had a surgical intervention. Six patients (2.4%) died. Conclusion: The main cause of bleeding was peptic ulcer. The majority of patients had either an H. pylori infection or an offending drug use. Since the etiology of bleeding was amenable to treatment, the rate of endoscopic and surgical treatment and mortality were low in our patients.

Özet

Amaç: Endoskopik tedavi çağında, varis dışı üst gastrointestinal kanama hala önemli bir mortalite ve morbidite nedenidir. Bu çalışmanın amacı, bir eğitim hastanesine varis dışı üst gastrointestinal kanamayla başvuran hastaları klinik ve endoskopik özellikleri açısından araştırmaktır. Metod: Varis dışı üst gastrointestinal kanamayla 1996-2001 tarihleri arasında başvuran 250 hasta retrospektif olarak incelendi. Bulgular: Hastaların ortalama yaşı 59 olup %34.4'ü kadındı. Hastaların %59.6'sında aspirin/non-steroidal anti-inflamatuar ilaç (NSAİİ), %2.8'inde steroid ve %9.6'inde varfarin kullanımı vardı. Vakaların %31.8'i daha önce de gastrointestinal sistem kanaması geçirmişti. En sık görülen lezyon peptik ülserdi (%49.2), bunu duodenal ve gastrik erozyonlar (%19.2) ile mide tümörleri (% 10.8) izliyordu. Lezyonlar mide (%40), duodenum (%33.6), gastrojejunal bileşke (%4.4) ve özofagus (% 4.4) yerleşimliydi. H. pylori varlığı 48 olguda araştırıldı, bunların %79.2'sinde pozitif bulundu. Aktif kanama belirtisi olan 33 hastaya endoskopik tedavi uygulandı. Endoskopik tedavisi başarısız olan 3 hastayla beraber 7 hastaya (%2.8) cerrahi işlem uygulandı. Hastaların 6'sı (%2.4) kaybedildi. Sonuç: Çalışmamızda en önemli kanama nedeni peptik ülserdi. Hastaların büyük bir çoğunluğunda kanamaya neden olacak en az bir risk faktörü vardı (H. pilori veya ilaç kullanımı). Kanama nedenleri kolay tedavi edilebildiğinden, hasta grubumuzda endoskopik ve cerrahi tedavi oranı ile mortalite düşük bulundu.

🔖

Cite This Article

AKBAŞ, T., İMERYÜZ, N., BOZBAŞ, A., TÖZÜN, N. (2010). Marmara Üniversitesi Hastanesine varis dışı üst gastrointestinal kanama ile başvuran hastaların değerlendirilmesi. Marmara Medical Journal, Cilt: 23 - Sayı: 3, 339–346. https://ajindex.com/articles/280890

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Van Leerdam ME, Tygat GN. Review article:Halicobacter pylori infection in peptic ulcer hemorrhage. Aliment Pharmacol Ther 2002:16 (suppl 1)66-78
  2. Vreeburg EM, Snel P, de Bruijne JW, Bartelsman JF, Rauws EA, Tytgat GN. Acute upper gastrointestinal bleeding in the Amsterdam area: incidence, diagnosis and clinical outcome. Am J Gastroenterol 1997; 92:236-43
  3. Brullet E, Campo R, Calvet X, Coroleu D, Rivero E, Sim¨® Deu J. Factors related to the failure of endoscopic injection therapy for bleeding gastric ulcer. Gut 1996; 39:155-8
  4. Blatchford O, Davidson LA, Murray WR, Blatchford M, Pell J. Acute upper gastrointestinal haemorrhage in west of Scotland: case ascertainment study. BMJ 1997;315:510-4
  5. Marmo R, Koch M, Cipolletta L, Capurso L, Pera A, Bianco MA, et al. Predictive factors of mortality from nonvariceal upper gastrointestinal hemorrhage: s multicenter study. Am J Gastroenterol 2008;103:1639-47 6) Laine L, Peterson WL. Bleeding peptic ulcer. N Engl J Med 1994;331:717-27
  6. Cohen M, Sapoznikov B, Niv Y. Primary and secondary nonvariceal upper gastrointestinal bleeding. J Clin Gastroenterol 2007;41:810-3 8) Laine L. Gastrointestinal bleeding. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J, (eds). Harrision's Principles of Internal Medicine. 17 th ed. New York: McGraw-Hill Companies, 2008;257-60 9) Pilotto A, Ferrucci L, Scarcelli C, Niro V, Di mario F, Seripa D, et al. Usefulness of the comprehensive geriatric assesment in older patients with upper gastrointestinal bleeding: a two-year follow-up study. Dig Dis 2007;25:124-8
  7. Marshall JK, Collins SM, Gafni A. Prediction of resource utilization and case cost for acute nonvariceal upper gastrointestinal hemorrhage at a Canadian community hospital. Am J Gastroenterol 1999;94:1841-6
  8. Ong TZ, Hawkey CJ, Ho KY. Nonsteroidal anti-inflammatory drug use is a significant cause of peptic ulcer disease in a tertiary hospital in Singapore: a prospective study. J Clin Gastroenterol 2006; 40:795-800
  9. Vreeburg EM, de Bruijne HW, Snel P, Bartelsman JW, Rauws EA, Tytgat GN. Previous use of non-steroidal anti-inflammatory drugs and anticoagulants: the influence on clinical outcome of bleeding gastroduodenal ulcers. Eur J Gastroenterol Hepatol 1997; 9:41-4
  10. Thomopoulos KC, Vagenas KA, Vagianos CE, Margaritis VG, Blikas AP, Katsakoulis EC, et al. Changes in aetiology and clinical outcome of acute upper gastrointestinal bleeding during the last 15 years. Eur J Ga